HSP90 Heat-Shock Proteins
- Name
- HSP90 Heat-Shock Proteins
- Accession Number
- DBCAT001479
- Description
Not Available
- Drugs
Drug Drug Description Alvespimycin Investigated for use as an antineoplastic agent for solid tumors, advanced solid tumours or acute myeloid leukaemia. Efungumab Efungumab is under investigation in clinical trial NCT00217815 (Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer). - Drugs & Drug Targets
Drug Target Type Alvespimycin Heat shock protein HSP 90-alpha target